Navigation Links
Cautious Approach Needed Before Any Decision on EU Out-of-Quota Sugar Exports Is Taken
Date:1/27/2010

SAO PAULO, Jan. 27 /PRNewswire/ -- Following the announcement by the European Commission to propose additional out-of-quota sugar exports for an amount of 500,000 tonnes, the Brazilian Sugarcane Industry Association (UNICA) reiterates its call on the Commission for a cautious approach, taking into consideration all interests at stake and potential dramatic consequences.

According to UNICA, the European Commission is sending wrong signals to EU farmers, who are being incentivised to more sowings ahead of the next campaign, although current higher sugar prices on the global market are merely conjectural. "This short-sighted policy is potentially damaging for the EU sugar market as EU farmers will be left with additional surpluses to be exported; this when global prices return below the EU price," warned Marcos Jank, President and CEO.

While it acknowledges the exceptional character of the circumstances leading to the Commission's announcement, UNICA calls on the European Commission to strictly limit the additional out-of-quota sugar exports to the 2009/2010 marketing year and to explicitly rule out any precedent the decision would set for the following marketing years. Finally, UNICA reiterates its call for engaging the parties to the EC-Export subsidies on the sugar WTO panel, Australia, Brazil and Thailand. "We understand that the conformity of the Commission's decision with its international obligations is open to interpretation. The draft Regulation should therefore be submitted to the WTO for a conformity assessment prior to its adoption," concluded Marcos Jank.

ABOUT UNICA

The Brazilian Sugarcane Industry Association (UNICA) represents
'/>"/>

SOURCE The Brazilian Sugarcane Industry Association (UNICA)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. New Pharmacogenomic Approach: 454 Life Sciences and Perlegen to Collaborate in Drug Response Sequencing Study
2. Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
3. Monsanto and Devgen Describe New Approach to Insect-Protection
4. Fate Therapeutics Created by Leading Stem Cell Scientists to Pursue New Approaches to Stem Cell Therapies
5. New approach may render disease-causing staph harmless
6. Copolymers block out new approaches to microelectronics at NIST
7. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
8. Quiznos Selects Halogen for Fresh Approach to Talent Management
9. Countering an approaching water crisis
10. Novel Approach to Treat Alzheimers and Other Diseases Offered by Targeting Cell Membrane RAFTS
11. Abbott Scientists Present a New Approach for Treating Attention-Deficit Hyperactivity Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sep. 02, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report briefly ... sequencing technologies, and their applications. Current large and ... developing them. Various applications of sequencing are described ...
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... announced the addition of Jain PharmaBiotech,s new report ... their offering. The markets for gene therapy ... approved gene therapy product and it is marketed in ... markets are estimated for the years 2014-2024. The estimates ...
(Date:9/2/2015)... , Sept. 2, 2015  Neurotech Pharmaceuticals, ... enrolled in the multicenter Phase 2 clinical trial ... long-term treatment of recurrent subfoveal choroidal neovascularization secondary ... is a unique vascular endothelial growth factor (VEGF) ... implant. "This landmark proof-of-concept study will ...
(Date:9/2/2015)... BioLight Life Sciences Investments ... a firm that invests in, manages and commercializes ... today that presentations highlighting its IOPtiMate™ system for ... the Ophthalmology Futures European Forum and the XXXIII ... Refractive Surgeons ("ESCRS"), both taking place in the ...
Breaking Biology Technology:Global DNA Sequencing Technologies Report 2015: Profiles of 130 Companies Involved in Sequencing and their 140 Collaborations 2Global Gene Therapy Market Study 2015-2024 - Technologies, Markets and Companies Analysis 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 2Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 3Neurotech Announces First Patient Enrolled in Novel Anti-VEGF Encapsulated Cell Therapy Study 4Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today ... ended December 31, 2008."2008 was a transition year for ... focused on lower-risk reformulations of previously-approved drugs. We achieved ... the difficult economic environment, we were unable to attract ...
... Insmed Inc. (Nasdaq: INSM ), a developer of ... March 23, 2009, NASDAQ issued a notice further extending the ... price and those rules requiring a minimum market value of ... effect through Friday, July 17, 2009, and the original rules ...
... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ... patient enrolment in its U.K. clinical trial to ... REOLYSIN(R) in combination with gemcitabine (Gemzar(R)) in patients ... neck. The principal investigators are Dr. Johann de ...
Cached Biology Technology:ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 2ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 3ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 4ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 5ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 6ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results 7Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
(Date:8/10/2015)... and TELTOW, Germany , August 10, ... (SMI), a world leader in Eye Tracking Technology for ... its OEM Eye Tracking Platform for integration into all ... contains reference designs for seamless integration of eye tracking ... reality HMDs and augmented reality smart glasses. Omnivision,s leading ...
(Date:8/5/2015)... -- According to a new market research ... Vertical (BFSI, Airport, IT & Telecom, Utilities, Education, Defense ... 2020", published by MarketsandMarkets, defines and segments the Physical ... The global PIAM Market is estimated to grow from ... at a CAGR of 14.9 % from 2014 to ...
(Date:8/3/2015)... Synaptics, Inc. (Nasdaq: SYNA ), the ... members of the executive management team will present to ... Leadership Forum on Tuesday, August 11, 2015 at 1:00 ... the Sonnenalp Resort in Vail, CO. ... information. An audio webcast of the event will be ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... of new coal-fired power plants in the United States ... due to the high cost of the requirement ... of carbon dioxide, an important greenhouse gas. But an ... construction moving again, allowing the nation to fend off ...
... by researchers at UC Davis Medical Center suggests that ... be a result of their brains not telling their ... blood oxygen levels are more common than we thought ... Masud Seyal, a professor of neurology at UC Davis ...
... , Thanks to our ability to learn and to remember, we ... of. However, we are only just beginning to get the gist ... or forgets something. What we do know is that changes in ... these structural changes account for that well-known phenomenon that it is ...
Cached Biology News:MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3Forgotten but not gone -- how the brain takes care of things 2Forgotten but not gone -- how the brain takes care of things 3
... The wide mini ReadySub-Cell GT cell and ... horizontal gel electrophoresis of nucleic acids in agarose ... buffer tank, lid with cables and electrodes, and ... and 220-240 V, provides output of 10-300 V, ...
... and you reduce the chance of error. ... 8000. Developed using Beckman Coulters extensive experience ... electrophoresis technology, the CEQ 8000 is a ... automatically fills the capillary array with a ...
... 2000 Capillary Electrophoresis System uses revolutionary ... electrophoresis (SPE), urine protein electrophoresis and ... accurate analysis. The system is truly ... and no staining to process patient ...
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
Biology Products: